$3.00 (-1.96%)

Volume: 457.221k

Closed: Mar 28, 2023

Hollow Logo Score: 0.917
Arbutus Biopharma Corporation Stock
$3.00 (-1.96%)

Volume: 457.221k

Closed: Mar 28, 2023

Score Hollow Logo 0.917

Arbutus Biopharma Corporation Stock Statistics

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2023-03-13 - 2023-03-28 BUY 1.35
2023-03-10 - 2023-03-13 SELL 5.71
2023-03-07 - 2023-03-10 BUY -4.44
2023-03-01 - 2023-03-07 HOLD 4.27
2023-02-28 - 2023-03-01 SELL 1.08

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE